Proteoglycan(g009) effective in enhancing antitumor immunity

Details Proteoglycan(g009) effective in enhancing antitumor immunity Proteoglycan(g009) effective in enhancing antitumor immunity

C - Chemistry, Metallurgy

07

K

C07K 14/375 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2097820

This invention relates to a proteoglycan G 009 separated from cultured Ganoderma lucidum IY 009 and containing .beta.-glucose, .alpha.-glucose, galactose, .alpha.-mannose and fructose as saccharide components, and glycine, alanine, histidine, arginine, valine, aspartic acid, threonine, isoleucine, serine, leucine, glutamic acid, tyrocine, proline, phenylalanine and methionine as protein components. The proteoglycan G 009 exhibits antitumoral and immunostimulating activities.

Affiliated with

Also associated with

Rating

Proteoglycan(g009) effective in enhancing antitumor immunity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Proteoglycan(g009) effective in enhancing antitumor immunity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Proteoglycan(g009) effective in enhancing antitumor immunity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1663878